Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J (1988) Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Clin Infect Dis 10:551–559. https://doi.org/10.1093/clinids/10.3.551

Article  CAS  Google Scholar 

Tragiannidis A, Groll AH (2009) Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis. Clin Microbiol Infect 15:82–86. https://doi.org/10.1111/j.1469-0691.2009.02986.x

Article  PubMed  Google Scholar 

Rai S, Yadav S, Kumar D, Kumar V, Rattan V (2016) Management of rhinomaxillary mucormycosis with posaconazole in immunocompetent patients. J Oral Biol Craniofac Res 6:S5–8. https://doi.org/10.1016/j.jobcr.2016.10.005

Article  PubMed  PubMed Central  Google Scholar 

Ansari MA, Fatima Z, Hameed S (2016) Antifungal action of methylene blue involves mitochondrial dysfunction and disruption of redox and membrane homeostasis in C. albicans. Open Microbiol J 10:12–22. https://doi.org/10.2174/1874285801610010012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Madhavan Y, Sai KV, Shanmugam DK, Manimaran A, Guruviah K, Mohanta YK et al (2022) Current treatment options for COVID-19 associated mucormycosis: present status and future perspectives. J Clin Med 11:3620. https://doi.org/10.3390/jcm11133620

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pathak L, Tripathi A, Nayyar SS, Kurkure R, Yadav A, Mishra J et al (2023) Management of post-COVID mucormycosis at a tertiary care center in Northern India. Egypt J Otolaryngol 39:19. https://doi.org/10.1186/s43163-023-00388-1

Article  Google Scholar 

Rao KM, Pooja N (2022) Management of mucormycosis in post COVID-19 patients and its outcome in a tertiary care center: our experience. Indian J Otolaryngol Head Neck Surg 74:3344–3351. https://doi.org/10.1007/s12070-022-03197-9

Article  PubMed  PubMed Central  Google Scholar 

Sahu M, Shah M, Mallela VR, Kola VR, Boorugu HK, Punjani AAR et al (2023) COVID-19 associated multisystemic mucormycosis from india: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome. Infection 51:407–416. https://doi.org/10.1007/s15010-022-01891-y

Article  CAS  PubMed  Google Scholar 

Özbek L, Topçu U, Manay M, Esen BH, Bektas SN, Aydın S et al (2023) COVID-19–associated mucormycosis: a systematic review and meta-analysis of 958 cases. Clin Microbiol Infect 29:722–731. https://doi.org/10.1016/j.cmi.2023.03.008

Article  PubMed  PubMed Central  Google Scholar 

Dogra S, Arora A, Aggarwal A, Passi G, Sharma A, Singh G et al (2022) Mucormycosis amid COVID-19 crisis: pathogenesis, diagnosis, and novel treatment strategies to combat the spread. Front Microbiol 12:794176. https://doi.org/10.3389/fmicb.2021.794176

Article  PubMed  PubMed Central  Google Scholar 

Prakash H, Chakrabarti A (2019) Global epidemiology of mucormycosis. J Fungi 5:26. https://doi.org/10.3390/jof5010026

Article  CAS  Google Scholar 

Skiada A, Pavleas I, Drogari-Apiranthitou M (2020) Epidemiology and diagnosis of mucormycosis: an update. J Fungi 6:265. https://doi.org/10.3390/jof6040265

Article  CAS  Google Scholar 

Goel K, Dhillon J, Yadav V, Bhagat S, Aggarwal A (2023) Post-Covid isolated mandibular mucormycosis in a patient with chronic kidney disease: A case report. Indian J Otolaryngol Head Neck Surg 75:2538–2543. https://doi.org/10.1007/s12070-023-03838-7

Article  PubMed Central  Google Scholar 

Dasukil S, Boyina KK, Sarkar S, Hallur V, Nayak A, Mishra AK et al (2022) Management of Covid associated mucormycosis of mandible: A mountain beneath a Molehill—A lesson learnt. Indian J Otolaryngol Head Neck Surg 74:3481–3484. https://doi.org/10.1007/s12070-021-02925-x

Article  PubMed  Google Scholar 

Topazian RG, Goldberg MH, Hupp JR (2002) Oral and maxillofacial infections, 4th edn. W.B. Saunders, Philadelphia

Google Scholar 

Jawanda MK, Narula R, Gupta S, Sharma V, Sidhu SK, Kaur N (2021) Mixed infections (Mucormycosis, actinomycosis and Candidiasis) leading to maxillary osteomyelitis in a diabetic mellitus patient in post COVID phase: first case report. Acta Med Hradec Kralove Czech Repub 64:218–223. https://doi.org/10.14712/18059694.2022.5

Article  CAS  Google Scholar 

Vehreschild JJ, Birtel A, Vehreschild MJGT, Liss B, Farowski F, Kochanek M et al (2013) Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 39:310–324. https://doi.org/10.3109/1040841X.2012.711741

Article  CAS  PubMed  Google Scholar 

Almannai M, Imran H, Estrada B, Siddiqui AH (2013) Successful treatment of Rhino-Orbital mucormycosis with posaconazole and hyperbaric oxygen therapy. Pediatr Hematol Oncol 30:184–186. https://doi.org/10.3109/08880018.2013.770587

Article  PubMed  Google Scholar 

Salmanton-García J, Seidel D, Koehler P, Mellinghoff SC, Herbrecht R, Klimko N et al (2019) Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn). J Antimicrob Chemother 74:3315–3327. https://doi.org/10.1093/jac/dkz344

Article  CAS  PubMed  Google Scholar 

Chen L, Krekels EHJ, Verweij PE, Buil JB, Knibbe CAJ, Brüggemann RJM (2020) Pharmacokinetics and pharmacodynamics of posaconazole. Drugs 80:671–695. https://doi.org/10.1007/s40265-020-01306-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

John BV, Chamilos G, Kontoyiannis DP (2005) Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 11:515–517. https://doi.org/10.1111/j.1469-0691.2005.01170.x

Article  CAS  PubMed  Google Scholar 

Couch L, Theilen F, Mader JT (1988) Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol - Head Neck Surg 114:791–794. https://doi.org/10.1001/archotol.1988.01860190095032

Article  CAS  PubMed  Google Scholar 

Segal E, Menhusen MJ, Simmons S (2007) Hyperbaric oxygen in the treatment of invasive fungal infections: A Single-Center experience. Isr Med Assoc J 9:355–357

PubMed  Google Scholar 

Liu Z, Tang J, Sun Y, Gao L (2019) Effects of photodynamic inactivation on the growth and antifungal susceptibility of rhizopus oryzae. Mycopathologia 184:315–319. https://doi.org/10.1007/s11046-019-00321-2

Article  PubMed  Google Scholar 

Pal R, Ansari MA, Saibabu V, Das S, Fatima Z, Hameed S (2018) Nonphotodynamic roles of methylene blue: display of distinct antimycobacterial and anticandidal mode of actions. J Pathog 2018:1–13. https://doi.org/10.1155/2018/3759704

Article  CAS  Google Scholar 

Werthman-Ehrenreich A (2021) Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med 42:264.e5-264.e8

Article  Google Scholar